You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adriamycin

Showing 1 - 25 of 728
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma Trial in Guangzhou (Sintilimab plus chemo)

Recruiting
  • Soft Tissue Sarcoma
  • Sintilimab plus chemotherapy
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab vedotin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 20, 2023

Soft Tissue Sarcoma Trial in Zhengzhou (Anrotinib HCl combined with adriamycin)

Recruiting
  • Soft Tissue Sarcoma
  • Anrotinib hydrochloride combined with adriamycin
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Feb 27, 2023

Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte

Not yet recruiting
  • Early-stage Breast Cancer
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Feb 22, 2023

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

Active, not recruiting
  • Ann Arbor Stage III Non-Hodgkin Lymphoma
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 28, 2023

Classical Hodgkin Lymphoma Trial in Seattle (drug, other, biological)

Recruiting
  • Classical Hodgkin Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston

Active, not recruiting
  • Metastatic Urothelial Carcinoma
  • +2 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Urothelial Carcinoma, Bladder Cancer Trial in Houston (Abiraterone acetate, Durvalumab, Methotrexate)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Abiraterone acetate
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 2, 2022

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
Has Results
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Bone Scan
  • +7 more
  • (no location specified)
Jan 18, 2023

Hodgkin Disease Trial in Worldwide (Brentuximab vedotin, Doxorubicin, Vinblastine)

Completed
Has Results
  • Hodgkin Disease
  • Brentuximab vedotin
  • +3 more
  • Aurora, Colorado
  • +13 more
Jun 17, 2022

Advanced Soft-tissue Sarcoma Trial in Nicosia, Amman (Doxorubicin, Cyclophosphamide Oral Product, Prednisolone)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Nicosia, Cyprus
  • +1 more
Jul 1, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)

Recruiting
  • Solid Tumor
  • KRAS Mutation-Related Tumors
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Endometrial Cancer Trial (MK-2870, Doxorubicin, Paclitaxel)

Not yet recruiting
  • Endometrial Cancer
  • MK-2870
  • +2 more
  • (no location specified)
Nov 10, 2023

Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
May 24, 2023

Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Cologne, Germany
    University Hospital of Cologne
Aug 5, 2022

Solitary Fibrous Tumors Trial in Italy (Trabectedin, Adriamycin, Dacarbazine)

Recruiting
  • Solitary Fibrous Tumors
  • Prato, Firenze, Italy
  • +5 more
Oct 29, 2021

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Desmoid Tumor Trial in GuangZhou (Liposome doxorubicin, Saline Solution)

Recruiting
  • Desmoid Tumor
  • Liposome doxorubicin
  • Saline Solution
  • GuangZhou, Guangdong, China
    Sun Yat-sen University cancer center
Sep 29, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

Recruiting
  • Acute Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +13 more
Jan 26, 2023